Investing.com - Morgan Stanley (NYSE: MS) raised its price target on Grail , Inc. (NASDAQ: GRAL) to $38.00 from $20.00 on Monday, while maintaining an Equalweight rating on the cancer detection ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback